We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$158M
AUM Growth
-$7.14M
Cap. Flow
-$21.7M
Cap. Flow %
-13.81%
Top 10 Hldgs %
5.64%
Holding
474
New
40
Increased
153
Reduced
231
Closed
49

Top Buys

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$752K
2
IT icon
Gartner
IT
+$681K
3
TT icon
Trane Technologies
TT
+$681K
4
ETN icon
Eaton
ETN
+$660K
5
PLD icon
Prologis
PLD
+$658K

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$854K
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$778K
3
IEX icon
IDEX
IEX
+$731K
4
TSLA icon
Tesla
TSLA
+$719K
5
YUMC icon
Yum China
YUMC
+$714K

Sector Composition

Rank Sector Weight
1 Healthcare 22.36%
2 Technology 15.51%
3 Financials 14.54%
4 Industrials 9.65%
5 Energy 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
451
Seres Therapeutics
MCRB
$45M
– –
-808
Closed -$38.5K
MRK icon
452
Merck
MRK
$322B
– –
-6,766
Closed -$697K
MRSN
453
DELISTED
Mersana Therapeutics
MRSN
– –
-414
Closed -$13.2K
NKE icon
454
Nike
NKE
$64.1B
– –
-6,850
Closed -$655K
PAYC icon
455
Paycom
PAYC
$7.88B
– –
-2,134
Closed -$553K
PFG icon
456
Principal Financial Group
PFG
$24.3B
– –
-8,928
Closed -$643K
PMVP icon
457
PMV Pharmaceuticals
PMVP
$57.1M
– –
-16,534
Closed -$102K
SPGI icon
458
S&P Global
SPGI
$124B
– –
-1,764
Closed -$645K
STOK icon
459
Stoke Therapeutics
STOK
$1.84B
– –
-7,893
Closed -$31.1K
TSLA icon
460
Tesla
TSLA
$1.18T
– –
-2,873
Closed -$719K
TSVT
461
DELISTED
2seventy bio
TSVT
– –
-28,308
Closed -$111K
TXN icon
462
Texas Instruments
TXN
$248B
– –
-4,051
Closed -$644K
ULTA icon
463
Ulta Beauty
ULTA
$21.8B
– –
-1,625
Closed -$649K
VNDA icon
464
Vanda Pharmaceuticals
VNDA
$304M
– –
-48,530
Closed -$210K
VTYX
465
DELISTED
Ventyx Biosciences
VTYX
– –
-2,825
Closed -$98.1K
YUMC icon
466
Yum China
YUMC
$15.7B
– –
-12,821
Closed -$714K
CERE
467
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-2,895
Closed -$63.2K
IMGN
468
DELISTED
Immunogen Inc
IMGN
– –
-17,174
Closed -$273K
MRTX
469
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-2,684
Closed -$117K
PNT
470
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-9,954
Closed -$66.4K
EQRX
471
DELISTED
EQRx, Inc. Common Stock
EQRX
– –
-54,639
Closed -$121K
ICPT
472
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-25,272
Closed -$469K
CEN
473
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
– –
-13,699
Closed -$290K
HZNP
474
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-7,381
Closed -$854K
15 16 17 18
19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Virtus ETF Advisers held 474 positions worth $158M, down 4.3% from $165M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Virtus ETF Advisers withdrew a net $21.7M in Q4 2023, closing 49 positions and reducing 231 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $854K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Virtus ETF Advisers opened a new position in Expedia Group worth $932K.

  • Virtus ETF Advisers's largest Q4 2023 buy was Expedia Group: 6,139 shares worth $932K.
  • Virtus ETF Advisers added most to Pioneer Natural Resource Co. in Q4 2023, an estimated $535K increase.
  • Virtus ETF Advisers's biggest Q4 2023 reduction was VICI Properties, cutting an estimated $659K.
  • Virtus ETF Advisers fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $854K.
  • Virtus ETF Advisers's ten largest holdings make up 5.6% of its $158M portfolio in Q4 2023.
  • Virtus ETF Advisers opened 40 new positions and closed 49 in Q4 2023.
  • Virtus ETF Advisers's portfolio value fell 4.3% quarter-over-quarter to $158M.

Based on Virtus ETF Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.